Newsletter | June 5, 2026

06.05.26 -- Understanding The Real Risk When Using Research-Grade Material For In-Human Testing

SPONSOR

Webinar: Smarter DNA, Healthier Cells: Circular Single Stranded DNA in Gene Editing

Explore how non-viral gene editing is advancing HSPC therapies with Touchlight’s mbDNA™ platform. This webinar highlights progress in achieving efficient HDR-based gene insertion while preserving stem cell viability and function. Attendees will learn how mbDNA compares with viral vectors and supports scalable, precise gene engineering workflows for inherited blood disorders using emerging CRISPR and LNP-based delivery strategies. Click here to learn more.

FOCUS ON SUPPLY CHAIN

Understanding Real Risk Using Research-Grade Material For In-Human Testing

When it comes to putting medicine made with research-grade raw materials into people, experts say: proceed with extreme caution. "There are a lot less controls than you think," says Lawrence Thompson in this segment of Cell & Gene Live "Viability On The Line." Beyond material quality, facility controls play a critical role. He doesn't choose materials unless he can visit the facility and put eyes on their processes, he said.

Addressing A Critical Drug Shortage

A critical drug shortage demanded regulatory action, importation support, and patient program readiness. See how integrated QA, 3PL, and PSP capabilities delivered operational readiness in three months.

FOCUS ON CLINICAL TRIALS

Reframing Vendor Selection: Beyond Price And Past Relationships

An RFP is more than a budget tool — it’s a strategic communication document that guides vendors, clarifies expectations, and enables informed, data-driven sponsor decisions. Here's all you need to know.

Execution Without Direction: The Hidden Risk In Outsourced Clinical Trials

Follow along as industry experts unpack the underlying causes of these challenges and consider whether clinical oversight monitors represent a necessary evolution or simply add an additional layer of complexity.

Measuring What Can't Be Seen: How PTSD Clinical Trials Prove A Drug Works

PTSD trials expose one of the hardest problems in modern drug development, a reliance on clinician-administered and patient-reported scales to determine whether a therapy truly works.

Building A Competitive, Patient‑First Future For Rare Diseases In Europe

The EURORDIS Round Table shows how Europe can align regulatory reform and patient-centered design to strengthen competitiveness and improve access to rare disease innovation across Member States.

Transparency In Action: The Key To Trust And Efficiency

Trust is the backbone of clinical research. Learn how you can utilize transparency and data integrity to protect participants, meet regulatory standards, and drive medical innovation.

CLINICAL TRIALS SOLUTIONS

Diversity In STEM Scholarships In APAC And North America - Avance Clinical

Creating Custom Listings Faster With AI - Revvity Signals Software, Inc.

Connect With Cell & Gene: